Skip to main content
. 2014 Apr 8;14:191. doi: 10.1186/1471-2334-14-191

Table 2.

Symptoms in critical patients with HFRS

Symptoms Survivors (n = 46) Non-survivors (n = 29) P value a
Dyspnea, n (%)
12 (26.1)
14 (48.3)
.049
Fever, n (%)
46 (100)
29 (100)
1.000
Nausea, n (%)
35 (76.1)
21 (72.4)
.722
Vomiting, n (%)
27 (58.7)
17 (58.6)
.995
Anepithymia, n (%)
12 (26.1)
4 (13.8)
.206
Hematemesis, n (%)
5 (10.9)
2 (6.9)
.866
Dark stools, n (%)
7 (15.2)
4 (13.8)
.865
Abdominal distention, n (%)
23 (50)
13 (44.8)
.662
Cough, n (%)
17 (37)
6 (20.7)
.137
Expectoration, n (%)
13 (28.3)
4 (13.8)
.145
Spasm, n (%)
3 (6.5)
3 (10.3)
.875
Agitation, n (%)
16 (34.8)
24 (82.8)
< .001
Fatigue, n (%)
21 (45.7)
10 (34.5)
.339
Lethargy, n (%)
11 (23.9)
10 (34.5)
.323
Hemoptysis, n (%)
2 (4.3)
2 (6.9)
1.000
Blurred vision, n (%)
3 (6.5)
3 (10.3)
.875
Chills, n (%)
10 (21.7)
9 (31)
.367
Diarrhea, n (%)
9 (19.6)
6 (20.7)
.906
Stomachache, n (%)
19 (41.3)
11 (37.9)
.772
Headache, n (%)
22 (47.8)
10 (34.5)
.255
Dizziness, n (%)
13 (28.3)
9 (31)
.797
Lumbago, n (%)
30 (65.2)
14 (48.3)
.147
Chest distress, n (%)
22 (47.8)
13 (44.8)
.800
Short breath, n (%) 22 (47.8) 17 (58.6) .362

aSurvivors vs. non-survivors.